Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

European Stock Futures Mixed; German Industrial Production Weakens

Published 04/09/2021, 02:11 AM
Updated 04/09/2021, 02:11 AM
© Reuters.

By Peter Nurse 

Investing.com - European stock markets are seen trading in a mixed fashion at the open Friday, helped by further signs of a global economic recovery but concerns about the region’s Covid vaccination program remain.

At 3:10 AM ET (0710 GMT), the DAX futures contract in Germany traded 0.2% lower, while CAC 40 futures in France climbed 0.1% and the FTSE 100 futures contract in the U.K. rose 0.2%. 

Earlier Friday, China reported that its March factory gate prices rose at their fastest annual pace since July 2018, climbing 4.4% year-on-year, far above February’s 1.7% growth.

Although China set a modest GDP growth target of above 6% for 2021 earlier in the year, many expect the Asian economic super power’s growth to exceed 8%.

Back in Europe the economic news was less impressive, as Germany’s industrial production slumped 1.6% on the month in February, according to data released Friday, below the expected growth of 1.5%.

"It would need an explosion of manufacturing and construction activity in March to prevent the German economy from falling into contraction in the first quarter of the year," ING analyst Carsten Brzeski said in a note to clients.

Adding to these concerns has been growing worries over the safety of one of the most prominent vaccines against the virus. 

Italy, Spain and Belgium have joined other European countries in limiting the use of the AstraZeneca (NASDAQ:AZN) vaccine, even after the European Medicines Agency on Wednesday repeated that the benefits of the drug outweigh the risks of very rare cases of blood clots.

The lack of common guidelines within the EU over the use of the drug can only increase public hesitancy, slowing the chance of the region achieving widespread vaccination.

The concerns over this vaccine will make sure AstraZeneca remains in the spotlight Friday, especially after Australia announced it would be ordering 20 million extra doses of Pfizer’s rival drug, in a pivot away from the British-Swedish drug maker. 

Oil prices drifted Friday, with traders trying to digest the competing influences of rising supplies and a global economic recovery that is gradually gathering steam. 

U.S. crude futures traded 0.1% higher at $59.63 a barrel, while the Brent contract fell 0.2% to $63.07. 

Both contracts are on track to post a drop of between 2% and 3% this week following the decision late last week by the Organization of the Petroleum Exporting Countries and its allies, including Russia, to gradually increase supplies by 2 million barrels per day between May and July.

Elsewhere, gold futures fell 0.5% to $1,749.90/oz, while EUR/USD traded 0.2% lower at 1.1891.

 

Latest comments

No news today. Market will PUMP big time! BUY BUY BUY!! Let's keep this run going
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.